Home・Stock List・Design Therapeutics Inc

Design Therapeutics Inc

Closed

15.5 6.31

Buy Sell

Overview

Share price change

24h

Current

Min

14.75

Max

15.63

Key metrics
By Trading Economics
Income	-1.6M -18M
EPS	-0.29
Employees	54
EBITDA	534K -17M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+32.67% upside

Dividends
By Acuity
Next Earnings	5 Aug 2026

Market Stats
By TradingEconomics
Market Cap	90M 889M
Previous open	9.19
Previous close	15.5

Design Therapeutics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

4 Jul 2026, 23:51 UTC

Macro News

Correlated Moves

Bitcoin is higher as the Trump administration advances plans for a Strategic Bitcoin Reserve, with a federal purchase expected by Q4 2026.

4 Jul 2026, 23:41 UTC

Canada's Balance of Trade data set for July 7, 2026, forecasts a C$2.4 billion surplus amid cautious market optimism despite geopolitical tensions and U.S.-Canada trade concerns.

4 Jul 2026, 23:41 UTC

Brazil's July Inflation Rate Release Sparks Caution Amid Mixed Economic Signals and Global Monetary Policy Shifts

4 Jul 2026, 23:41 UTC

Brazil's June 2026 Inflation Rate Release Sparks Cautious Optimism Amid Easing Pressures and Global Economic Influences

4 Jul 2026, 23:41 UTC

Mexico's June 2026 Inflation Rate Release on July 9 Expected to Influence Market Sentiment Amid Global Economic Trends.

4 Jul 2026, 23:41 UTC

U.S. Exports Data Release on July 7, 2026, Expected to Reflect Resilience Amid Geopolitical Tensions and Market Optimism Following Record Highs

4 Jul 2026, 23:41 UTC

Mexico's Inflation Rate MoM Release on July 9 Expected to Reflect Global Economic Pressures Amid U.S. Monetary Policy Concerns.

4 Jul 2026, 23:41 UTC

U.S. Imports Data Release on July 7, 2026: Market Anticipates Impact of Tariffs and Global Trade Dynamics Amid Cautious Optimism for Economic Stabilization.

4 Jul 2026, 23:41 UTC

U.S. Trade Deficit Expected at $78.8 Billion Amid Weak Job Growth and Easing Geopolitical Tensions

4 Jul 2026, 23:32 UTC

Cryptocurrency Market Gains Amid Weak U.S. Job Data and Cautious Fed Outlook

4 Jul 2026, 23:32 UTC

Bitcoin and Ethereum rise amid positive market sentiment following disappointing U.S. jobs data and easing geopolitical tensions, while investors anticipate key economic releases next week.

4 Jul 2026, 23:32 UTC

U.S. job growth disappoints, shifting Fed rate hike expectations, while Eurozone PMI stabilizes and car registrations surge in Germany.

4 Jul 2026, 23:32 UTC

Cryptocurrency market shows recovery as Bitcoin and Ethereum post gains, while U.S. job growth disappoints, reducing Fed rate hike expectations ahead of July FOMC meeting.

4 Jul 2026, 23:21 UTC

Macro News

Correlated Moves

Ethereum is advancing today, buoyed by Federal Reserve Chair Kevin Warsh's remarks on easing inflation risks and strong market interest ahead of Pepeto's presale.

4 Jul 2026, 23:11 UTC

Correlated Moves

The Russell 2000 Index is trading lower in after-market hours, reflecting a decline since Friday's close amid limited momentum and macroeconomic influences.

4 Jul 2026, 23:11 UTC

Correlated Moves

After-market trading for the Dow Jones Index shows a decline, reflecting a cumulative drop since Friday's close amid shared macroeconomic factors with the S&P 500.

4 Jul 2026, 23:01 UTC

The FTSE 100 Index is lower in after-hours trading, reversing earlier gains. It remains above its 20-day moving average and near its one-month range.

4 Jul 2026, 23:01 UTC

Correlated Moves

Cardano is rising, supported by Ethereum's gains and positive market sentiment. The asset remains above its 20-day moving average, with strong performance over four sessions.

4 Jul 2026, 23:01 UTC

Macro News

The S&P 500 Index is lower in after-market hours amid rising memory chip costs and escalating geopolitical tensions following a Ukrainian drone attack.

4 Jul 2026, 23:01 UTC

The Nasdaq 100 Index is lower in after-hours trading, continuing a decline since Friday's close without any specific news to explain the movement.

4 Jul 2026, 22:51 UTC

Brazil's Retail Sales MoM data set for July 8, 2026, shows cautious optimism as analysts predict recovery from April’s -1.5% decline amid positive economic sentiment linked to World Cup events.

4 Jul 2026, 22:51 UTC

The DAX 30 Index is trading lower in after-market hours, reflecting a decline since Friday's close and contrasting with recent upward momentum.

4 Jul 2026, 22:41 UTC

Cautious Optimism Grows Ahead of MBA Mortgage Rate Release Amid Easing Inflation and Weaker Jobs Data

4 Jul 2026, 22:31 UTC

Japan's Current Account Data Release on July 7, 2026, Forecasts JPY 4.12 Trillion Surplus Amid Market Volatility and Global Economic Concerns.

4 Jul 2026, 22:31 UTC

Brazil's Central Bank to Discuss SELIC Rate Amid Mixed Economic Signals and Global Influences on July 6, 2026.

4 Jul 2026, 22:11 UTC

UK Housing Market Faces Continued Downward Pressure as RICS House Price Balance Forecasts -0.32% Amid Economic Challenges

4 Jul 2026, 21:51 UTC

Japan's Household Spending YoY data set for July 6, 2026, expected to decline amid cautious market sentiment and global economic pressures.

4 Jul 2026, 21:51 UTC

Japan's Household Spending Expected to Rise 1.4% in May Amid Mixed Economic Sentiment and Positive Service Sector Growth

4 Jul 2026, 21:01 UTC

Macro News

Brent crude prices are lower in after-market hours following a Ukrainian drone attack on an oil terminal in St. Petersburg, intensifying the fuel crisis in Russia.

4 Jul 2026, 20:21 UTC

ECB President Lagarde's upcoming speech sparks cautious market sentiment on Eurozone interest rate hikes amid easing inflation pressures.

Peer Comparison

Price change

Design Therapeutics Inc Forecast

Price Target

By TipRanks

32.67% upside

12 Months Forecast

Average 20.75 USD 32.67%

High 22 USD

Low 20 USD

Based on 5 Wall Street analysts offering 12 month price targets forDesign Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

5 ratings

Buy

Hold

Sell

Based on 5 analysts giving stock ratings to Design Therapeutics Inc - Dist in the past 3 months.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Design Therapeutics Inc

Design Therapeutics, Inc. a biopharmaceutical company, researches, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States. The company utilizes its GeneTAC platform to design and develop therapeutic candidates for inherited diseases caused by nucleotide repeat expansion. Its lead product candidates for potentially disease-modifying treatment comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function that brings to neurological, cardiac, and metabolic dysfunction; Myotonic Dystrophy Type-1, a dominantly-inherited, monogenic progressive neuromuscular disease affecting skeletal muscle, heart, brain, and other organs; Fuchs Endothelial Corneal Dystrophy, a genetic eye disease characterized by bilateral degeneration of corneal endothelial cells and progressive loss of vision; and Huntington's Disease, a dominantly inherited, monogenic neurodegenerative disease characterized by movement, cognitive, and psychiatric disorders. Design Therapeutics, Inc. was incorporated in 2017 and is headquartered in Carlsbad, California.